Cargando…
A hypothetical therapeutic effect of light peripheral panretinal photocoagulation in neovascular age-related macular degeneration
BACKGROUND: Vascular endothelial growth factor (VEGF) is a significant modulator of ocular angiogenesis, including that of neovascular age-related macular degeneration (nAMD). Intravitreal injection of anti-VEGF is the benchmark treatment for most retinal vascular diseases, including nAMD, diabetic...
Autores principales: | Mansour, Ahmad M, Tripathy, Koushik, Parodi, Maurizio Battaglia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Virtual Ophthalmic Research Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445313/ https://www.ncbi.nlm.nih.gov/pubmed/37641639 http://dx.doi.org/10.51329/mehdiophthal1457 |
Ejemplares similares
-
The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis
por: Huang, Chao, et al.
Publicado: (2021) -
Changes in Central Macular Thickness following Single Session Multispot Panretinal Photocoagulation
por: Watanachai, Nawat, et al.
Publicado: (2015) -
Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study
por: He, Feng, et al.
Publicado: (2019) -
A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
por: Sun, Yaoyao, et al.
Publicado: (2023) -
Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment?
por: Georgiadis, Odysseas, et al.
Publicado: (2014)